2831 - 2840 of 6255 Results
Title
Year
-
OPENTitle: Frequency of Parkinsonism and Parkinson Disease in African Americans in the Chicago CommunityJournal Name: The Journals of Gerontology: Series APublisher: Oxford University Press (OUP)Vol: 76Issue #: 7Start Page: 1340End Page: 1345Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/gerona/glab042Best OA location URL: https://academic.oup.com/biomedgerontology/article-pdf/76/7/1340/38620655/glab042.pdfCitation Count: 8
- Principal Component Analysis of Striatal and Extrastriatal D2 Dopamine Receptor Positron Emission Tomography in Manganese-Exposed Workers2021OPENTitle: Principal Component Analysis of Striatal and Extrastriatal D2 Dopamine Receptor Positron Emission Tomography in Manganese-Exposed WorkersJournal Name: Toxicological SciencesPublisher: Oxford University Press (OUP)Vol: 182Issue #: 1Start Page: 132End Page: 141Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/toxsci/kfab045Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8285020Citation Count: 5
-
OPENTitle: Investigation of USP30 inhibition to enhance Parkin-mediated mitophagy: tools and approachesJournal Name: Biochemical JournalPublisher: Portland Press Ltd.Vol: 478Issue #: 23Start Page: 4099End Page: 4118Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1042/bcj20210508Best OA location URL: https://portlandpress.com/biochemj/article-pdf/478/23/4099/925639/bcj-2021-0508.pdfCitation Count: 26
- Development of a multiplexed targeted mass spectrometry assay for LRRK2-phosphorylated Rabs and Ser910/Ser935 biomarker sites2020OPENTitle: Development of a multiplexed targeted mass spectrometry assay for LRRK2-phosphorylated Rabs and Ser910/Ser935 biomarker sitesJournal Name: Biochemical JournalPublisher: Portland Press Ltd.Vol: 478Issue #: 2Start Page: 299End Page: 326Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1042/bcj20200930Best OA location URL: https://portlandpress.com/biochemj/article-pdf/478/2/299/902526/bcj-2020-0930.pdfCitation Count: 40
-
OPENTitle: Rab GTPases in Parkinson's disease: a primerJournal Name: Essays in BiochemistryPublisher: Portland Press Ltd.Vol: 65Issue #: 7Start Page: 961End Page: 974Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1042/ebc20210016Best OA location URL: https://portlandpress.com/essaysbiochem/article-pdf/65/7/961/926977/ebc-2021-0016c.pdfCitation Count: 16
- Sustained functional benefits after a single set of injections with abobotulinumtoxinA using a 2-mL injection volume in adults with cervical dystonia: 12-week results from a randomized, double-blind, placebo-controlled phase 3b study2021OPENTitle: Sustained functional benefits after a single set of injections with abobotulinumtoxinA using a 2-mL injection volume in adults with cervical dystonia: 12-week results from a randomized, double-blind, placebo-controlled phase 3b studyJournal Name: PLOS ONEPublisher: Public Library of Science (PLoS)Vol: 16Issue #: 2Start Page: e0245827End Page: e0245827Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pone.0245827Best OA location URL: https://doi.org/10.1371/journal.pone.0245827Citation Count: 10
- The ExTINGUISH Trial: A Phase-2B Randomized Placebo-Controlled Trial of Inebilizumab in Anti-NMDA Receptor Encephalitis2022OPENTitle: The ExTINGUISH Trial: A Phase-2B Randomized Placebo-Controlled Trial of Inebilizumab in Anti-NMDA Receptor EncephalitisJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 99Issue #: 23_Supplement_2Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/01.wnl.0000903316.50895.83Best OA location URL: https://n.neurology.org/content/neurology/99/23_Supplement_2/S39.full.pdfCitation Count: 2
-
OPENTitle: A Severe Case of Lupus CerebritisJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 99Issue #: 23_Supplement_2Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/01.wnl.0000903100.95793.8aBest OA location URL: https://n.neurology.org/content/neurology/99/23_Supplement_2/S9.full.pdfCitation Count: 1
-
OPENTitle: Interfacility Transfers for Seizure-Related Emergencies in the United StatesJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 99Issue #: 24Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/wnl.0000000000201319Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/9757868Citation Count: 5
-
OPENTitle: A Remote Longitudinal Observational Study of Individuals at Genetic Risk for Parkinson DiseaseJournal Name: Neurology GeneticsPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 8Issue #: 5Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/nxg.0000000000200008Best OA location URL: https://escholarship.org/content/qt15w1h7j8/qt15w1h7j8.pdfCitation Count: 7